Scholar Rock and the Miami Project to Cure Paralysis Present Preclinical Data Demonstrating Therapeutic Potential of SRK-015 in Spinal Cord Injury at 35th Annual National Neurotrauma Symposium

http://pipelinereview.com/index.php/2017071165199/Small-Molecules/Scholar-Rock-and-the-Miami-Project-to-Cure-Paralysis-Present-Preclinical-Data-Demonstrating-Therapeutic-Potential-of-SRK-015-in-Spinal-Cord-Injury-at-35th-Annual-National.html

CAMBRIDGE, MA, USA I July 10, 2017 I Scholar Rock, a biotechnology company focused on discovering and developing drugs that selectively target growth factors in the disease microenvironment, today announced the presentation of data from its SRK-015 antibody program, in collaboration…